• Lifestyle
More

    Obesity-associated protein promotes leukemia development

    Must Read

    Indian Oil Corporation limited to invest Rs1,689 crore in Andhra Pradesh

    To meet the growing demand for petroleum products, including petrol, diesel and LPG in the State, Indian...

    Country’s COVID recovery rate reaches 94.11 pct

    India has leaped across a significant milestone in its fight against COVID. The number of new daily...

    Dharampal Gulati, owner of MDH, passes away at 97

    'Mahashay' Dharampal Gulati, the owner of masala brand MDH Spices passed away on December 3. He was...

    A protein associated with obesity plays a significant role in the development of leukemia as well as in drug response, researchers have found.

    A new study has revealed that FTO — the protein associated with fat mass and obesity — plays a critical cancer-promoting role by regulating expression of a set of genes through a mechanism involving ribonucleic acid (RNA) modification and thereby increasing the reproduction of leukemia cells and prohibiting drug response.

    In 2011, Jianjun Chen, Associate Professor at the University of Chicago, US, made the first observation that FTO erases m6A methylation — the most impactful modificator in the RNAs.

    In the study, Chen showed that the m6A modification can be reversed.

    For the study, the team analysed a microarray dataset of 100 human acute myeloid leukemia (AML) samples from patients and nine normal control samples as well as other large-scale microarray datasets of AML samples.

    They found that FTO was highly expressed in various subtypes of leukemia samples such as those that contained chromosome crossover — genetic exchange between chromosomes — or mutations in certain genes.

    The high level of FTO expression contributed to cancer cells multiplying and surviving and also promoted the development of leukemia in animal models and the non-response of cancer cells to therapeutic agents.

    Additionally, researchers found that genes like ASB2 and RARA, which were reported to inhibit leukemia cell growth and/or mediate the response of leukemia cells to therapeutic agents, were suppressed in the AML samples with higher FTO expression.

    The suppression of these genes was attributed to FTO-controlled decreased stability of their mRNA and was connected to FTO’s m6A demethylase activity.

    “Our study shows, for the first time, the functional importance of the m6A modification machinery in leukemia,” Chen said, adding that this could help find new therapeutic strategy for leukemia treatment.

    The study was published online in the journal Cancer Cell.

    LEAVE A REPLY

    Please enter your comment!
    Please enter your name here

    This site uses Akismet to reduce spam. Learn how your comment data is processed.

    Latest News

    Country’s COVID recovery rate reaches 94.11 pct

    India has leaped across a significant milestone in its fight against COVID. The number of new daily...

    Country’s COVID recovery rate reaches 94.11 pct

    India has leaped across a significant milestone in its fight against COVID. The number of new daily cases have been below the...

    Dharampal Gulati, owner of MDH, passes away at 97

    'Mahashay' Dharampal Gulati, the owner of masala brand MDH Spices passed away on December 3. He was 97 years old.

    SC makes CCTVs, audio recording compulsory at all interrogation rooms, jails

    The Supreme Court directed the Centre on Wednesday to install CCTV cameras and recording equipment at the offices of investigating agencies, including...

    Fourth round of talks between Central govt and farmers to be held in New Delhi today

    Fourth round of talks between the government and farmers' representative will be held in New Delhi today. The third round of talks...

    More Articles Like This

    - Advertisement -